Federated Hermes’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1
Closed -$1K 2280
2021
Q4
$1K Buy
+1
New +$4 ﹤0.01% 2139
2020
Q4
Sell
-229
Closed -$1K 2302
2020
Q3
$1K Sell
229
-7
-3% -$33 ﹤0.01% 2184
2020
Q2
$1K Sell
236
-16
-6% -$54 ﹤0.01% 2165
2020
Q1
$1K Buy
252
+15
+6% +$65 ﹤0.01% 2142
2019
Q4
$1K Sell
237
-16
-6% -$90 ﹤0.01% 2128
2019
Q3
$1K Buy
+253
New +$1.72K ﹤0.01% 2125
2018
Q3
Sell
-71,931
Closed -$1M 2310
2018
Q2
$1M Sell
71,931
-3,470
-5% -$58.6K ﹤0.01% 1288
2018
Q1
$1.16M Buy
75,401
+66,849
+782% +$956K ﹤0.01% 1179
2017
Q4
$99K Sell
8,552
-185
-2% -$2.75K ﹤0.01% 1595
2017
Q3
$166K Buy
8,737
+1,617
+23% +$33.3K ﹤0.01% 1526
2017
Q2
$172K Buy
+7,120
New +$156K ﹤0.01% 1547
2016
Q2
Sell
-10,477
Closed -$352K 2159
2016
Q1
$352K Buy
+10,477
New +$330K ﹤0.01% 1371
2015
Q3
Sell
-125
Closed -$6K 2025
2015
Q2
$6K Buy
+125
New +$5.27K ﹤0.01% 1773

Other funds holding PGEN

Federated Hermes's PGEN Position: Q1 2022 in Review

Federated Hermes sold out of Precigen (PGEN) in Q1 2022, closing a stake of 1 share — an estimated $1K sold.

Federated Hermes first reported a position in PGEN in Q2 2015 and held it in 13 quarters. The position peaked at $1.16M in Q1 2018. 173 funds tracked by Wall St. Rank hold PGEN as of Q1 2022.

  • Federated Hermes reported no remaining Precigen position as of Q1 2022 after selling out during the quarter.
  • Federated Hermes sold 1 Precigen share in Q1 2022, an estimated $1K.
  • Federated Hermes first reported a position in Precigen in Q2 2015 and held it in 13 quarters.
  • Federated Hermes's Precigen position peaked at $1.16M in Q1 2018.
  • 173 funds tracked by Wall St. Rank held Precigen as of Q1 2022.

Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.